WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 3'7901 Infant (under 12 months) mortality rate: 152
GDP / capita (US$): 7'7741 Child (under 5 years) mortality rate: 162

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 2'977  2'969  2'964  2'963  2'968  3'076  3'545  3'096 
Births 41  41  42  42  42  41  74  69 
Surviving infants 40  41  41  41  41  39  71  66 
Pop. less than 5 years 210  215  218  216  216  197  389  331 
Pop. less than 15 years 603  603  605  608  613  795  1'077  941 
Female 15-49 years 736  744  753  765  777  862  900  837 

Number of reported case

(Click for retrospective incidence data for Armenia)
Diphtheria
Japanese encephalitis
Measles 10  15  879 
Mumps 15  38  71  3'431 
Pertussis 30  11  10  469 
Polio*
Rubella 673 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Armenia)
Vaccine year result method % card seen                                                
BCG 2009  100  DHS   92  99  96  96  95  99  97 
DTP1 2009  99  DHS   92  97  98  98  98  97 
DTP3 2009  95  DHS   92  95  95  95  94  93  93 
HepB_BD          98  95  95  94  92  97 
HepB3 2009  90  DHS   92  95  95  95  94  93  55 
Hib3          95  95  98  94 
JapEnc         
MCV 2009  95  DHS   92  97  97  97  97  96  92 
MCV2          97  97  98  97  96  94 
PCV1         
PCV3         
Pol3 2009  95  DHS   92  96  96  96  96  94  96 
Rota1          92 
Rota_last          90 
Rubella1          97  97  97  96 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Armenia)
BCG 99  96  96  95  99  97 
DTP1 97  98  98  98  97  97 
DTP3 95  95  95  94  93  93 
HepB3 95  95  95  94  93  55 
HepB_BD 98  95  95  94  92  97 
Hib3 95  95  95  48 
MCV 97  97  97  97  96  92 
MCV2 97  97  98  97  96  94 
PCV3
Pol3 96  96  96  96  94  96 
Rota_last 33 

Number of districts in the country 51  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 94
From 80 to 89% 6
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaP 18 months; Yes
DTwPHibHep 6, 12, 18 weeks; Yes
HepB birth; Yes
MMR 1, 6 years; Yes
OPV 6, 12, 18 weeks; 18 months; 6 years; Yes
Rotavirus 6, 12 weeks; Yes
Td 6, 15-16, 26-30, 36-40, 46-50, 56-60 years; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2010-2015  2010-2015  2010-2015  2010-2015  2007-2010    2007-2010 
Nº of districts with microplans that include activities to raise immunization coverage number     51  51  51    51 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 51  51  51  51  51  51  51 
Nº districts with DTP3 coverage >=80% number 51  51  51  51  50  48  17 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  98  94  33 
Nº districts with measles (MCV1) coverage >=95% number 47  47  48  46  42  30   
% of districts with MCV1 coverage >=95% From 0 to 100% 92  92  94  90  82  59   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%   65      60    33 

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.